Drug-labels.com

Mylan-Lovastatin: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
20 mg, 40 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Mylan-Lovastatin

ABOUT THIS MEDICATION

MYLAN-LOVASTATIN is the brand name for the substance lovastatin available only on prescription from your physician.

What the medication is used for:

Your physician has prescribed MYLAN-LOVASTATIN to help lower your elevated levels of cholesterol associated with normal or elevated triglycerides.

Elevated cholesterol can cause coronary heart disease (CHD) by clogging the blood vessels (atherosclerosis) that carry oxygen and nutrients to the heart. MYLAN-LOVASTATIN is used to slow progression of atherosclerosis in the coronary arteries (blood vessels of the heart).

As part of your treatment plan to lower cholesterol, and depending on your health and lifestyle, your physician may recommend a diet to reduce cholesterol and other measures such as exercise and weight control.

What it does:

Lovastatin is one of the class of medicines known as Lipid Metabolism Regulators. They inhibit, in other words block, an enzyme that is necessary for the body to make cholesterol. In this way, less cholesterol is produced in the liver. Medicines like this one are prescribed along with, and not as a substitute for, a special diet and other measures. Lovastatin is used to lower the levels of cholesterol (particularly Low Density Lipoprotein (LDL) cholesterol) and other fats in the blood. This may help prevent heart disease if caused by cholesterol clogging the blood vessels or slow the progression of atherosclerosis (hardening) of the arteries that nourish your heart, so-called coronary heart disease (CHD).

When it should not be used:

Do not take MYLAN-LOVASTATIN if you are:

  • allergic to any of its components
  • diagnosed with active liver disease

    • pregnant or breast-feeding

    • taking any of the following medicines:

      • certain antifungal medicines (such as itraconazole, ketoconazole, posaconazole, or voriconazole)
      • HIV protease inhibitors (such as indinavir, nelfinavir, ritonavir, and saquinavir)
      • certain hepatitis C virus protease inhibitors (such as boceprevir or telaprevir)
      • certain antibiotics (such as erythromycin, clarithromycin, or telithromycin1)
      • the antidepressant nefazodone1
      • medicines containing cobicistat
      • the immunosuppressant cyclosporine

Ask your physician or pharmacist if you are not sure if your medicine is listed above.

What the medicinal ingredient is:

Lovastatin

What the non-medicinal ingredients are:

Butylated hydroxyanisole, microcrystalline cellulose, magnesium stearate and pregelatinized starch. MYLAN-LOVASTATIN 20 mg tablets also contain FD & C Blue No. 2 Aluminum Lake. MYLAN-LOVASTATIN 40 mg tablets contain FD & C Blue No. 2 Aluminum Lake and D & C Yellow No. 10 Aluminum Lake.

What dosage forms it comes in:

Tablets 20 mg and 40 mg.

WARNINGS AND PRECAUTIONS

Before taking MYLAN-LOVASTATIN, tell your physician or pharmacist if you:

  • are pregnant, intend to become pregnant, are breast-feeding or intend to breast-feed
  • have thyroid problems
  • regularly drink three or more alcoholic drinks daily

  • are taking any other cholesterol lowering medication such as fibrates (gemfibrozil, fenofibrate), niacin or ezetimibe
  • are taking any other medications, including prescription, nonprescription and natural health products as drug interactions are possible
  • have a family history of muscular disorders
  • had any past problems with the muscles (pain, tenderness), after using an HMG-CoA reductase inhibitor (“statin”) such as atorvastatin (Lipitor), fluvastatin (Lescol), pravastatin (Pravachol), rosuvastatin (Crestor) or simvastatin (ZOCOR®), or have developed an allergy or intolerance to them
  • have kidney or liver problems
  • have diabetes. Slightly increased blood sugar can occur when you take MYLAN-LOVASTATIN. Discuss with the physician your risk of developing diabetes
  • have undergone surgery or other tissue injury

1 not marketed in Canada

  • do excessive physical exercise
  • are of childbearing age. Cholesterol compounds are essential elements for the development of a fetus. Cholesterol-lowering drugs can harm the fetus. If you are of childbearing age, discuss with your physician the potential hazards to the fetus and the importance of birth control methods.
  • become pregnant. MYLAN-LOVASTATIN should not be used by pregnant women. If you become pregnant, discontinue use immediately and discuss with your physician.

When starting or increasing the dose of MYLAN-LOVASTATIN, or at any time, if you experience any unexplained muscle pain, tenderness or weakness, you must report promptly to your physician.

Be sure to tell your physician or healthcare provider you are taking MYLAN-LOVASTATIN before undergoing any major elective surgery or if you have any other new major medical issues.

INTERACTIONS WITH THIS MEDICATION

You should tell your physician about all drugs that you are using or plan to use, including those obtained without a prescription, while taking MYLAN-LOVASTATIN. You should also tell any physician who is prescribing a new medication for you that you are taking MYLAN-LOVASTATIN.

Because taking MYLAN-LOVASTATIN with any of the following drugs or substances can increase the risk of muscle problems (see Side effects and what to do about them), it is particularly important to tell your physician if you are taking:

  • antifungal agents (such as itraconazole, ketoconazole, posaconazole, or voriconazole)
  • the antibiotics (erythromycin, clarithromycin, telithromycin1, and fusidic acid [oral1 or intravenous1]
  • HIV protease inhibitors (such as indinavir, nelfinavir, ritonavir, and saquinavir)
  • boceprevir or telaprevir (drugs used to treat hepatitis C virus infection)
  • the antidepressant nefazodone1
  • medicines containing cobicistat
  • fibric acid derivatives (such as gemfibrozil and bezafibrate)
  • cyclosporine (immunosuppressant)
  • danazol
  • verapamil or diltiazem (drugs used to treat high blood pressure or angina)
  • amiodarone (a drug used to treat an irregular heartbeat)
  • colchicine (a medicine used for gout)

1 not marketed in Canada

  • grapefruit juice (which should be avoided while taking MYLAN-LOVASTATIN

It is also important to tell your physician if you are taking corticosteroids, anticoagulants (drug that prevents blood clots, such as warfarin, phenprocoumon or acenocoumarol), digoxin (a drug used to treat heart problems), niacin, or fenofibrate, another fibric acid derivative.

Some of these have already been listed in the above section “When it should not be used”.

The safety of this medicine has not been established in adolescents and children.

PROPER USE OF THIS MEDICATION

Usual Dose:

  • Take your medication exactly as your physician instructed. Do not change the dose unless directed by a physician. It is usually recommended as a single dose with the evening meal or in two divided doses with the morning and evening meals. Your physician may adjust your dose to a maximum of 80 mg/day, given in single doses with the evening meal or divided doses with the morning and evening meals. It is important to continue taking the tablets as instructed. Do not alter the dosage or stop taking the medicine without consulting your physician.
  • Carefully follow any measures that your physician has recommended for diet, exercise or weight control.
  • When taking MYLAN-LOVASTATIN, you should avoid consuming grapefruit juice.
  • When taking MYLAN-LOVASTATIN concurrently with cholestyramine or any other resin, an interval of at least two hours should be maintained between the two drugs.
  • Keep your appointments regularly with your physician so that your blood can be tested and your progress checked at proper intervals.
  • Avoid drinking large quantities of alcohol.
  • Do not start taking any other medicines unless you have discussed the matter with your physician.
  • Let your physician know if you suffer a severe injury, or severe infection.
  • If you have to undergo any kind of surgery, tell your physician about the planned surgery; and also inform the dentist or the physician in charge that you are taking this or any other medicine.

Overdose:

Contact your physician immediately.

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If you miss taking a tablet at its usual time, take it as soon as possible. But, if it is too close to the time of your next dose: take only the prescribed dose at the appointed time. Do not take a double dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Along with its intended action, any medication may cause unwanted effects. Most people do not have any problem when taking this medicine; but if you notice any of the following reactions, check with your physician as soon as possible:

Fever

Blurred vision

Muscle effects

Some other side effects that may occur, generally do not require medical attention, and may come and go during treatment. But if any of the following persist or become troublesome, do check with your physician or pharmacist:

Constipation, diarrhea, gas, stomach upset, nausea

Pain in the abdomen

Headache, dizziness

Skin rash

Poor memory

Memory loss

Confusion

Depression

Erectile dysfunction

Possible side effects reported with some statins:

  • Breathing problems including persistent cough and/or shortness of breath or fever.
  • Sleep Disturbances, including insomnia and nightmares.
  • Mood related disorders.

Side effects such as myalgia (muscle pain), myopathy (muscle disease with aching or weakness [that is very rare may not go away after stopping lovastatin]), rhabdomyolysis (a muscle wasting disease), associated tenderness, and rare cases of rhabdomyolysis leading to kidney failure have been reported with other drugs of this class, known as HMG-CoA reductase inhibitors (“statins”), including lovastatin.

As these muscle problems are on rare occasions serious, you should contact your physician promptly if you experience any of the following:

  • muscle pain that you cannot explain
  • muscle tenderness or muscle weakness
  • generalized weakness, especially if you do not feel well (i.e. fever or fatigue)
  • brownish or discoloured urine

See your physician regularly to check your cholesterol level and to check for side effects. Your doctor should do blood tests to check your liver before you start taking MYLAN-LOVASTATIN and if you have any symptoms of liver problems while you take MYLAN-LOVASTATIN.

Contact your physician promptly if you experience muscle pain, tenderness, or weakness. This is because on rare occasions, muscle problems can be serious, including muscle breakdown resulting in kidney damage.

This risk of muscle breakdown is greater for patients taking higher doses of MYLAN-LOVASTATIN. This risk of muscle breakdown is greater for patients with abnormal kidney function.

Lovastatin can cause abnormal blood test results. Your physician will decide when to perform blood tests and will interpret the results.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptoms / effectsTalk with your physician or pharmacistStop taking drug and seek immediate emergency medical attention
Only if severeIn all cases
UnknownIncreased Blood Sugar: frequent urination, thirst and hunger✓
RareAllergic Reaction: rash, hives, swelling of the face, lips, tongue or throat difficulty swallowing or breathing✓
Brownish or discoloured urine✓
Liver problems: upper belly pain, nausea, vomiting, loss of appetite, dark/brown urine, yellow skin and eyes, itchy skin, pale stools✓
Generalized weakness, especially if you do not feel well✓
Unexplained muscle pain✓
Muscle tenderness or muscle weakness✓

This is not a complete list of side effects. For any unexpected effects while taking MYLAN-LOVASTATIN, contact your physician or pharmacist.

HOW TO STORE IT

Store your tablets at room temperature (15 C - 30 C), in a tightly closed container, away from heat and direct light, and out of damp places, such as the bathroom or kitchen.

Keep all medicines out of the reach of children.

Do not use outdated medicine.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  1. 1. Report online at www.healthcanada.gc.ca/medeffect
  2. 2. Call toll-free at 1-866-234-2345
  3. 3.

    Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document can be found at: www.mylan.ca.

The full product monograph prepared for health professionals can be obtained by contacting the sponsor, Mylan Pharmaceuticals ULC at: 1-800-575-1379

Revised on: March 26, 2014

Mylan Pharmaceuticals ULC

Etobicoke, ON M8Z 2S6

1-800-575-1379

www.mylan.ca

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02243127

Revision date stated in the text: March 26, 2014

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mylan-Lovastatin

Rx or OTC
Prescription (Rx)?
DIN 02243127, 02243129
Schedule(s) PRESCRIPTION
Active ingredient(s) Lovastatin
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AA HMG CoA reductase inhibitors, plain lipid modifying drugs
          1. C10AA02 Lovastatin
Company MYLAN PHARMACEUTICALS ULC
Current status Cancelled Post Market
Current status date August 2, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
02243127 20 MG Tablet Cancelled Post Market August 2, 2017
02243129 40 MG Tablet Cancelled Post Market August 2, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.